Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 722 of 1,261
  1. US 9193718

    Quinazoline derivative and application thereof

    FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  2. US 9193709

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  3. US 9192681

    Oligomer-amino acid conjugates

    Nektar Therapeutics · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  4. US 9192683

    Methods of treating disease with FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  5. US 9193701

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  6. US 9192630

    Transplantation of neural cells

    The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  7. US 9192629

    Isolated renal cells and uses thereof

    REGENMEDTX, LLC · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  8. US 9192644

    Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders

    The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  9. US 9192628

    Treatment method for relapsing-remitting multiple sclerosis

    REGENEX LLC · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  10. US 9192606

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  11. US 9192578

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  12. US 9193801

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  13. US 9193739

    Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  14. US 9193956

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  15. US 9193722

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  16. US 9192650

    Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  17. US 9192590

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  18. US 9187413

    Peripherally restricted FAAH inhibitors

    The Regents of the University of California · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  19. US 9186325

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  20. US 9186362

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  21. US 9187530

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  22. US 9186406

    Compositions containing nucleosides and manganese and their uses

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  23. US 9187541

    Anti-microbial peptides and methods of use thereof

    The Regents of the University of California · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  24. US 9187497

    Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.